Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study
Digestive and Liver Disease · 2024-09 · 56 (9) · 1605-1613
DOI: 10.1016/j.dld.2024.02.009 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2024-09. Verfasst von R Varnier und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Research on Healthcare Performance (RESHAPE, Inserm U1290), Université Claude Berna…. Hauptthemen laut MEDLINE: Bevacizumab, Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Research on Healthcare Performance (RESHAPE, Inserm U1290), Université Claude Bernard Lyon 1, Lyon, France.
- Department of Digestive Oncology, Institut du Cancer Avignon-Provence, Avignon, France.
- Department of Gastroenterology and Digestive Oncology, Hôpital Pitié Salpêtrière, Paris, France.
- Department of Surgery, Centre Léon Bérard, Lyon, France.
- Department of Gastroenterology and Digestive Oncology, Hôpital Privé Jean Mermoz, Lyon, France.
- Department of Hepato-Gastroenterology and Digestive Oncology, Centre Hospitalier Universitaire de Dijon, Dijon, France.
Zitieren
APA
Varnier, R., Toullec, C., Philonenko, S., Dupré, A., Artru, P., Hafliger, E., Drouillard, A., Torregrosa, C., Pernot, S., McLellan, P., Lecomte, T., Moulin, V., Lécaille, C., Touchefeu, Y., Locher, C., Taieb, J., & Coutzac, C. (2024). Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease, 56(9), 1605-1613. https://doi.org/10.1016/j.dld.2024.02.009
Vancouver
Varnier R, Toullec C, Philonenko S, Dupré A, Artru P, Hafliger E, et al. Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study. Digestive and Liver Disease. 2024;56(9):1605-1613. doi:10.1016/j.dld.2024.02.009
BibTeX
@article{Varnier2024,
author = {Varnier, R and Toullec, C and Philonenko, S and Dupré, A and Artru, P and Hafliger, E and Drouillard, A and Torregrosa, C and Pernot, S and McLellan, P and Lecomte, T and Moulin, V and Lécaille, C and Touchefeu, Y and Locher, C and Taieb, J and Coutzac, C},
title = {Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study},
journal = {Digestive and Liver Disease},
year = {2024},
volume = {56},
number = {9},
pages = {1605--1613},
doi = {10.1016/j.dld.2024.02.009}
}
EUVIMED